Clinical Trials Directory

Trials / Unknown

UnknownNCT01268722

Balloon Angioplasty Versus Primary Stenting for the Treatment of Femoropopliteal Artery Chronic Total Occlusions

Balloon Angioplasty Versus Self-expanding Stent for Recanalization of Chronic Total Occlusions of the Femoral Artery

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
University of Patras · Academic / Other
Sex
All
Age
30 Years
Healthy volunteers
Not accepted

Summary

This is a multicenter double-arm randomized trial investigating plain balloon angioplasty versus primary placement of self-expanding nitinol stents after endovascular recanalization of femoral CTOs. Study will recruit up to 200 patients to be adequately powered for detection of a significant difference in vessel patency after 1 year.

Detailed description

Primary placement of new-generation nitinol stents compared to plain old balloon angioplasty has shown encouraging long-term results in the femoropopliteal artery. However, there is complete lack of data about performance of new-generation nitinol stents in the treatment of chronic total occlusions (CTO) of the Femoral artery. This is a multicenter double-arm randomized trial investigating plain balloon angioplasty versus primary placement of self-expanding nitinol stents after endovascular recanalization of femoral CTOs. Study will recruit up to 200 patients to be adequately powered for detection of a significant difference in vessel patency after 1 year.

Conditions

Interventions

TypeNameDescription
DEVICEBalloon angioplastyThis arm will include patients randomized to undergo the treatment of a chronic total occlusion of the femoropopliteal artery with the use of balloon angioplasty
DEVICEPrimary stentingThis arm will include patients randomized to undergo primary stenting of the femoropopliteal chronic total occlusion

Timeline

Start date
2010-12-01
Primary completion
2013-12-01
Completion
2016-12-01
First posted
2010-12-31
Last updated
2012-04-06

Locations

5 sites across 3 countries: Greece, Italy, United Kingdom

Source: ClinicalTrials.gov record NCT01268722. Inclusion in this directory is not an endorsement.